Trademark search for:

DURIVAST

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results

Also check across:

USPTO Filing History

Key events recorded for this trademark application

2023-06-28 — Application filed
2023-07-27 — Sn assigned for sect 66a appl from ib
2023-07-28 — Application filed
2023-08-01 — Application filed
2024-01-18 — Assigned to examiner
2024-01-31 — Final disposition recorded
2024-02-01 — Office action issued
2024-02-21 — Office action issued
2024-02-21 — Office action issued
2024-03-19 — Office action issued
2024-09-06 — Application abandoned
2024-09-06 — Application abandoned
2024-09-06 — Final status recorded
2024-12-25 — Notification of possible opposition created, to be sent to ib
2024-12-25 — Notification of possible opposition sent to ib
2025-01-10 — Notification of possible opposition - processed by ib

Owner Information

Knight Therapeutics Europe S.A.
LU

Correspondent

Arendt & Medernach S.A.
41 A, avenue J.F. Kennedy
L-2082 Luxembourg,
LUXEMBOURG

Filing Details

Filing Date:
2023-06-28

Status Date:
2024-09-06

Category:
Pharmaceuticals

Filing Year:
2023

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.